NO980211D0 - Opplösning av 1-azabicyklo£2.2.2|oktan-3-amin,2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl| - Google Patents

Opplösning av 1-azabicyklo£2.2.2|oktan-3-amin,2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl|

Info

Publication number
NO980211D0
NO980211D0 NO980211A NO980211A NO980211D0 NO 980211 D0 NO980211 D0 NO 980211D0 NO 980211 A NO980211 A NO 980211A NO 980211 A NO980211 A NO 980211A NO 980211 D0 NO980211 D0 NO 980211D0
Authority
NO
Norway
Prior art keywords
diphenylmethyl
azabicyclo
methylethyl
octane
methoxy
Prior art date
Application number
NO980211A
Other languages
English (en)
Other versions
NO980211L (no
Inventor
Derek L Tickner
Morgan Meltz
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO980211D0 publication Critical patent/NO980211D0/no
Publication of NO980211L publication Critical patent/NO980211L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
NO980211A 1995-07-17 1998-01-16 Opplösning av 1-azabicyklo£2,2,2|oktan-3-amin, 2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl| NO980211L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US119195P 1995-07-17 1995-07-17
PCT/IB1996/000648 WO1997003984A1 (en) 1995-07-17 1996-07-04 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]

Publications (2)

Publication Number Publication Date
NO980211D0 true NO980211D0 (no) 1998-01-16
NO980211L NO980211L (no) 1998-03-16

Family

ID=21694832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980211A NO980211L (no) 1995-07-17 1998-01-16 Opplösning av 1-azabicyklo£2,2,2|oktan-3-amin, 2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl|

Country Status (26)

Country Link
US (1) US6008357A (no)
EP (1) EP0840735B1 (no)
JP (1) JP3043074B2 (no)
KR (1) KR100276989B1 (no)
CN (1) CN1068598C (no)
AR (1) AR002772A1 (no)
AT (1) ATE250600T1 (no)
AU (1) AU697553B2 (no)
CA (1) CA2227194C (no)
CO (1) CO4480720A1 (no)
CZ (1) CZ15098A3 (no)
DE (1) DE69630123T2 (no)
DK (1) DK0840735T3 (no)
ES (1) ES2205039T3 (no)
HK (1) HK1010195A1 (no)
HU (1) HUP9900238A3 (no)
IL (1) IL122655A0 (no)
MY (1) MY115734A (no)
NO (1) NO980211L (no)
NZ (1) NZ310539A (no)
PE (1) PE8798A1 (no)
PL (1) PL184261B1 (no)
PT (1) PT840735E (no)
RU (1) RU2136681C1 (no)
WO (1) WO1997003984A1 (no)
ZA (1) ZA966026B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861526B2 (en) 2002-10-16 2005-03-01 Pfizer Inc. Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
PL1713801T3 (pl) * 2004-02-02 2008-04-30 Pfizer Products Incorporated Sposób wytwarzania 1-(2S,3S)-2-benzhydrylo-N-(5-tert-butylo-2-metoksybenzylo)chinuklidyno-3-aminy
EP1812391A2 (en) * 2004-11-10 2007-08-01 Boehringer Ingelheim Chemicals, Inc. Process of making fentanyl intermediates
EP2376425A4 (en) * 2008-12-09 2012-12-26 Univ Florida KINASE INHIBITORS COMPOUNDS
US20160332962A1 (en) 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CN108341812A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 一种含奎宁环化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
NO168529C (no) * 1989-09-15 1992-03-04 Chiron Lab As Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
UA26401C2 (uk) * 1991-05-22 1999-08-30 Пфайзер Інк. Заміщеhі 3-аміhохіhуклідиhи
US5807867A (en) * 1991-05-31 1998-09-15 Pfizer Inc. Quinuclidine derivatives
US5604241A (en) * 1992-10-21 1997-02-18 Pfizer Inc. Substituted benzylaminoquinuclidines as substance P antagonists

Also Published As

Publication number Publication date
NZ310539A (en) 1998-11-25
PL324610A1 (en) 1998-06-08
ATE250600T1 (de) 2003-10-15
HUP9900238A2 (hu) 1999-05-28
WO1997003984A1 (en) 1997-02-06
CA2227194A1 (en) 1997-02-06
DE69630123D1 (en) 2003-10-30
IL122655A0 (en) 1998-08-16
DE69630123T2 (de) 2004-04-08
HUP9900238A3 (en) 2001-08-28
ES2205039T3 (es) 2004-05-01
PL184261B1 (pl) 2002-09-30
AU697553B2 (en) 1998-10-08
KR19990029058A (ko) 1999-04-15
EP0840735A1 (en) 1998-05-13
JP3043074B2 (ja) 2000-05-22
JPH10511102A (ja) 1998-10-27
MX9800538A (es) 1998-05-31
US6008357A (en) 1999-12-28
CZ15098A3 (cs) 1999-02-17
KR100276989B1 (ko) 2001-01-15
NO980211L (no) 1998-03-16
CN1068598C (zh) 2001-07-18
AU6134896A (en) 1997-02-18
DK0840735T3 (da) 2004-02-09
ZA966026B (en) 1998-01-16
RU2136681C1 (ru) 1999-09-10
CN1190970A (zh) 1998-08-19
PT840735E (pt) 2004-02-27
HK1010195A1 (en) 1999-06-17
MY115734A (en) 2003-08-30
PE8798A1 (es) 1998-03-02
CO4480720A1 (es) 1997-07-09
CA2227194C (en) 2002-02-12
AR002772A1 (es) 1998-04-29
EP0840735B1 (en) 2003-09-24

Similar Documents

Publication Publication Date Title
NO2007001I2 (no) Pioglitazon/metformin.
NO965020L (no) Opprettholdelse av sammensetningen av overförte data ved overlevering
CY2007024I1 (el) Kαινοφανη παραγωγα 3.3-διαφαινυλοπροπυλινων
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
FR2687753B1 (fr) Soufflet notamment pour joints homocinetiques.
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
IT1295645B1 (it) Apparecchio per l'elettroemanazione di principi attivi.
FI971674A (fi) Heterosyklisen ryhmän sisältämät di-tert-butyyli-fenoliyhdisteet, käyttökelpoisia tulehduksenvastaisina aineina
MA23779A1 (fr) Compose 9-substitue 2-(2-n-alkoxyphenyl) - purine -6- ones
DE59609043D1 (de) Feste Lösungen von 1,4-Diketopyrrolopyrrolen
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
NO980211D0 (no) Opplösning av 1-azabicyklo£2.2.2|oktan-3-amin,2-(difenylmetyl)-N-££2-metoksy-5-(1-metyletyl)fenyl|metyl|
IT1274571B (it) Procedimento per la preparazione di ¬r-(r*,r*)|-5-(3-clorofenil)-3- ¬2-(3,4-dimetossifenil)-1-metil-etil|-ossazolidin-2-one
DE69618045D1 (de) Clavulansäure Salz
FR2726854B1 (fr) Facade mobile notamment pour la fermeture d'espaces de rangement ou de meubles
TR199501675A2 (tr) Klavulanik asid tuzlari.
DZ1985A1 (fr) Dérivés d'indole substitués.
DE69828906D1 (de) Herstellung von 1,3 propandiolestern
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
ZA974929B (en) New forms of organic salts of N'N-diacetylcystine.
TR199600607A2 (tr) Insektisidlerin iticiligini azaltmaya mahsus para-hidroksifenilasetik asit.
DE69619812T2 (de) Kontinuierliche herstellung von 1,1-difluorethan
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
AU6958898A (en) Preparation of heterocycles using 1,3-dihalopropenes
AU1325095A (en) Novel 3-(substituted methyl)-4-oxa-1-azabicyclo{3.2.0}heptan-7-one derivatives useful as antitumor agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application